A novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis

European Journal of Immunology

Volumn 45, Issue 12, 2015, Pages 3339-3350

  Eschke, Maria ^a   Piehler, Daniel ^a   Schulze, Bianca ^a   Richter, Tina ^a   Grahnert, Andreas ^a   Protschka, Martina ^a   Müller, Uwe ^a   Köhler, Gabriele ^b   Höfling, Corinna ^a   Rossner, Steffen ^a   Alber, Gottfried ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KLINIKUM FULDA   (Germany)

Author keywords

CD4+ T cells; Cryptococcus neoformans; Fungal immunity; Immune reconstitution; Inflammation

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; RAG1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; HOMEODOMAIN PROTEIN; RAG-1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DONOR; EXPERIMENTAL MODEL; GRANULOMATOUS INFLAMMATION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MICROGLIA; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RECIPIENT; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL MOTION; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84951752441     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545689     Document Type: Article

References (41)

1. Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G. and Chiller, T. M., Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009. 23: 525-530.
2. Jarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N. et al., Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin. Infect. Dis. 2014. 58: 736-745.
3. Haddow, L. J., Colebunders, R., Meintjes, G., Lawn, S. D., Elliott, J. H., Manabe, Y. C., Bohjanen, P. R. et al., Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect. Dis. 2010. 10: 791-802.
4. Muller, M., Wandel, S., Colebunders, R., Attia, S., Furrer, H. and Egger, M., Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect. Dis. 2010. 10: 251-261.
5. Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L. and Wood, R., Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008. 22: 1897-1908.
6. Egger, M., May, M., Chene, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D. et al., Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002. 360: 119-129.
7. Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S. et al., Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin. Infect. Dis. 2010. 50: 291-322.
8. Longley, N., Harrison, T. S. and Jarvis, J. N., Cryptococcal immune reconstitution inflammatory syndrome. Curr. Opin. Infect. Dis. 2013. 26: 26-34.
9. Chang, C. C., Dorasamy, A. A., Gosnell, B. I., Elliott, J. H., Spelman, T., Omarjee, S., Naranbhai, V. et al., Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS 2013. 27: 2089-2099.
10. Boulware, D. R., Bonham, S. C., Meya, D. B., Wiesner, D. L., Park, G. S., Kambugu, A., Janoff, E. N. et al., Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J. Infect. Dis. 2010. 202: 962-970.
11. Lortholary, O., Fontanet, A., Memain, N., Martin, A., Sitbon, K. and Dromer, F., Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005. 19: 1043-1049.
12. Liechty, C. A., Solberg, P., Were, W., Ekwaru, J. P., Ransom, R. L., Weidle, P. J., Downing, R. et al., Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop. Med. Int. Health 2007. 12: 929-935.
13. Boulware, D. R., Meya, D. B., Bergemann, T. L., Wiesner, D. L., Rhein, J., Musubire, A., Lee, S. J. et al., Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010. 7: e1000384.
14. Sungkanuparph, S., Filler, S. G., Chetchotisakd, P., Pappas, P. G., Nolen, T. L., Manosuthi, W., Anekthananon, T. et al., Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Clin. Infect. Dis. 2009. 49: 931-934.
15. Shelburne, S. A., III, Darcourt, J., White, A. C., Jr., Greenberg, S. B., Hamill, R. J., Atmar, R. L. and Visnegarwala, F., The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 2005. 40: 1049-1052.
16. Bicanic, T., Meintjes, G., Rebe, K., Williams, A., Loyse, A., Wood, R., Hayes, M. et al., Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J. Acquir. Immune. Defic. Syndr. 2009. 51: 130-134.
17. Wiesner, D. L. and Boulware, D. R., Cryptococcus-related Immune Reconstitution Inflammatory Syndrome (IRIS): pathogenesis and its clinical implications. Curr. Fungal. Infect. Rep. 2011. 5: 252-261.
18. Worsley, C. M., Suchard, M. S., Stevens, W. S., Van, R. A. and Murdoch, D. M., Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS). AIDS Res. Ther. 2010. 7: 36-42.
19. Surh, C. D. and Sprent, J., Homeostasis of naive and memory T cells. Immunity 2008. 29: 848-862.
20. Saijo, K. and Glass, C. K., Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 2011. 11: 775-787.
21. Kreutzberg, G. W., Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996. 19: 312-318.
22. Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E. and Luster, A. D., IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 2002. 168: 3195-3204.
23. Boulware, D. R., Meya, D. B., Muzoora, C., Rolfes, M. A., Huppler, H. K., Musubire, A., Taseera, K. et al., Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N. Engl. J. Med. 2014. 370: 2487-2498.
24. Walker, N. F., Scriven, J., Meintjes, G. and Wilkinson, R. J., Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS 2015. 7: 49-64.
25. Huffnagle, G. B., Toews, G. B., Burdick, M. D., Boyd, M. B., McAllister, K. S., McDonald, R. A., Kunkel, S. L. et al., Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 1996. 157: 4529-4536.
26. Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C. et al., Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS 2012. 26: 1105-1113.
27. Kawakami, K., Qifeng, X., Tohyama, M., Qureshi, M. H. and Saito, A., Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol. 1996. 106: 468-474.
28. Lutz, J. E., Clemons, K. V. and Stevens, D. A., Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis. J. Antimicrob. Chemother. 2000. 46: 437-442.
29. Wormley, F. L., Jr., Perfect, J. R., Steele, C. and Cox, G. M., Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect. Immun. 2007. 75: 1453-1462.
30. Zhou, Q., Gault, R. A., Kozel, T. R. and Murphy, W. J., Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells. J. Immunol. 2007. 178: 5753-5761.
31. Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S. et al., Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014. 41: 14-20.
32. Chang, C. C., Omarjee, S., Lim, A., Spelman, T., Gosnell, B. I., Carr, W. H., Elliott, J. H. et al., Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome. J. Infect. Dis. 2013. 208: 1604-1612.
33. Barber, D. L., Mayer-Barber, K. D., Antonelli, L. R., Wilson, M. S., White, S., Caspar, P., Hieny, S. et al., Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 2010. 116: 3485-3493.
34. Wang, J., Gigliotti, F., Bhagwat, S. P., George, T. C. and Wright, T. W., Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia. PLoS Pathog. 2010. 6: e1001058.
35. Sun, H. Y. and Singh, N., Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr. Opin. Infect. Dis. 2009. 22: 394-402.
36. Croce, F., Piconi, S., Atzeni, F., Sarzi-Puttini, P., Galli, M. and Clerici, M., HIV/AIDS: epidemic update, new treatment strategies and impact on autoimmunity. Clin. Exp. Rheumatol. 2008. 26: S48-S52.
37. Datta, S. and Sarvetnick, N., Lymphocyte proliferation in immune-mediated diseases. Trends Immunol. 2009. 30: 430-438.
38. Krupica, T., Jr., Fry, T. J. and Mackall, C. L., Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 2006. 120: 121-128.
39. Decken, K., Kohler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K. et al., Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 1998. 66: 4994-5000.
40. Livak, K. J. and Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001. 25: 402-408.
41. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001. 29: e45.